King Charles visits Pharos AI project
By
Thomas.hauschildt1
1mo agoen
Source
bartslifesciences.orgKing Charles visits Pharos AI projectbartslifesciences.orgBarts Life Sciences welcome the visit of His Majesty The King to the Innovation Hub at Guy’s Cancer Centre, where we and partners are advancing cancer research through collaboration. At the Hub, scientists are working across disciplines, from data science to genomics, to integrate cutting-edge research directly into patient pathways, enabling more precise and tailored... The post King Charles visits Pharos AI project appeared first on Barts Life Sciences .
You might also wanna read
:max_bytes(150000):strip_icc():focal(749x0:751x2)/prince-charles-hospital-visit-1-051226-732d22bb6470474183b35d42817fe329.jpg)
King Charles Empathizes with Patient Over Metallic Taste Side Effect During Cancer Centre Visit
King Charles, 77, visited Guy's Cancer Centre in London and related to a patient about the "awful sort of metallic taste" caused by cancer t
:max_bytes(150000):strip_icc()/King-Charles-Sir-Robert-Ogden-Macmillan-Cancer-Centre-2026-052626-8bc4490dfb604e239171a4aabc3942ba.jpg)
King Charles Makes Rare Move at Cancer Center amid His Own Treatment
people.com·1mo ago
King Charles III's History of Promoting Homeopathy and Alternative Medicine
King Charles III has a long history of promoting homeopathy and other alternative medical treatments that lack scientific evidence. As Royal
Anthropic launches AI tool to speed up drug discovery
thechemicalengineer.com·3d ago
How a health-optimizing founder used AI to fight his cancer diagnosis
Conno Christou, a 35-year-old health-optimizing founder who tracked biomarkers, sleep, and supplements meticulously, was diagnosed with canc
How a health-optimizing founder used AI to fight his cancer diagnosis
Conno Christou, a 35-year-old health-optimizing founder who tracked biomarkers, sleep, and supplements meticulously, was diagnosed with canc

CGT Catapult teams with Korecyte Bio on low-oxygen detecting CAR-T program
bioprocessintl.com·1mo ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.